Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MA-T oral care gel for xerostomia in Sjogren's syndrome
jRCTs071240108Recruiting
- Sponsor
- Earth Corporation
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of MA-T oral care gel in xerostomia and Sjögren's syndrome, sponsored by Earth Corporation. Primary endpoint: Subjective improvement in xerostomia symptoms. Started Mar 2025; status: recruiting.
02
Drugs
MA-T oral care gel
03
Conditions
xerostomiaSjögren's syndrome
Beyond the preview
Go deeper on jRCTs071240108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071240108.